Question Number: 195
PDR Number: SQ22-000565
Date Submitted: 21/11/2022
Department or Body: Department of Health
100. The Australian Government has invested in a diverse portfolio of COVID-19 vaccines to secure early access, provide Australian’s flexibility of choice and enable the government to address variants of concern in the future. Quantities were procured well above population coverage to plan for contingencies and to meet the government’s on-going international commitments.
101. The details of Advance Purchase Agreements with pharmaceutical companies for the purchase of COVID-19 vaccines are commercial-in-confidence.
